We’ve recently updated our valuation analysis.

NHOA Valuation

Is NHOA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NHOA?

Other financial metrics that can be useful for relative valuation.

NHOA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.3x
Enterprise Value/EBITDA-14.7x
PEG Ration/a

Price to Sales Ratio vs Peers

How does NHOA's PS Ratio compare to its peers?

The above table shows the PS ratio for NHOA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average8.3x
ALENO Enogia SAS
4.4x23.3%€17.5m
ALENE Enertime
5.1xn/a€12.2m
ALHRS Hydrogen-Refueling-Solutions
22.3x44.1%€380.0m
PERR Gérard Perrier Industrie
1.2x6.6%€318.0m
NHOA NHOA
2.4x42.8%€251.5m

Price-To-Sales vs Peers: NHOA is good value based on its Price-To-Sales Ratio (2.4x) compared to the peer average (8.3x).


Price to Earnings Ratio vs Industry

How does NHOA's PE Ratio compare vs other companies in the European Electrical Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a6.2%
n/an/an/a

Price-To-Sales vs Industry: NHOA is expensive based on its Price-To-Sales Ratio (2.4x) compared to the European Electrical industry average (1.7x)


Price to Sales Ratio vs Fair Ratio

What is NHOA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NHOA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.4x
Fair PS Ratio1.3x

Price-To-Sales vs Fair Ratio: NHOA is expensive based on its Price-To-Sales Ratio (2.4x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).


Share Price vs Fair Value

What is the Fair Price of NHOA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate NHOA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate NHOA's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NHOA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€9.85
€25.00
+153.8%
20.0%€30.00€20.00n/a2
Nov ’23€10.04
€25.00
+149.0%
20.0%€30.00€20.00n/a2
Oct ’23€10.38
€20.00
+92.7%
0%€20.00€20.00n/a1
Sep ’23€12.76
€20.00
+56.7%
0%€20.00€20.00n/a1
Aug ’23€11.50
€20.00
+73.9%
0%€20.00€20.00n/a1
Jul ’23€9.80
€20.00
+104.1%
0%€20.00€20.00n/a1
Jun ’23€11.96
€20.00
+67.2%
0%€20.00€20.00n/a1
May ’23€13.04
€20.00
+53.4%
0%€20.00€20.00n/a1
Apr ’23€14.70
€20.00
+36.1%
0%€20.00€20.00n/a1
Mar ’23€13.42
€20.00
+49.0%
0%€20.00€20.00n/a1
Feb ’23€15.70
€25.00
+59.2%
0%€25.00€25.00n/a1
Jan ’23€17.22
€25.00
+45.2%
0%€25.00€25.00n/a1
Dec ’22€14.92
€25.00
+67.6%
0%€25.00€25.00n/a1
Nov ’22€20.50
€25.00
+22.0%
0%€25.00€25.00€10.041
Oct ’22€18.78
€25.00
+33.1%
0%€25.00€25.00€10.381
Sep ’22€19.50
€25.00
+28.2%
0%€25.00€25.00€12.761
Aug ’22€18.56
€25.00
+34.7%
0%€25.00€25.00€11.501
Jul ’22€17.20
€25.00
+45.3%
0%€25.00€25.00€9.801
Jun ’22€17.40
€25.00
+43.7%
0%€25.00€25.00€11.961
May ’22€17.78
€25.00
+40.6%
0%€25.00€25.00€13.041
Apr ’22€18.00
€19.00
+5.6%
0%€19.00€19.00€14.701
Mar ’22€18.95
€19.00
+0.3%
0%€19.00€19.00€13.421
Feb ’22€15.70
€16.00
+1.9%
0%€16.00€16.00€15.701
Jan ’22€13.05
€16.00
+22.6%
0%€16.00€16.00€17.221
Dec ’21€12.70
€15.75
+24.0%
11.1%€17.50€14.00€14.922
Nov ’21€9.40
€15.75
+67.6%
11.1%€17.50€14.00€20.502

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies